Multidrug-resistant Acinetobacter extremity infections in soldiers

被引:227
|
作者
Davis, KA [1 ]
Moran, KA
McAllister, CK
Gray, PJ
机构
[1] Brooke Army Med Ctr, Dept Med, Infect Dis Serv, MCHE,MDI, Ft Sam Houston, TX 78258 USA
[2] Walter Reed Army Med Ctr, Washington, DC 20307 USA
关键词
D O I
10.3201/1108.050103
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
War wound infection and osteomyelitis caused by multidrug-resistant (MDR) Acinetobacter species have been prevalent during the 2003-2005 military operations in Iraq. Twenty-three soldiers wounded in Iraq and subsequently admitted to our facility from March 2003 to May 2004 had wound cultures positive for Acinetobacter calcoaceticus-baumannii complex. Eighteen had osteomyelitis, 2 burn infection, and 3 deep wound infection. Primary therapy for these infections was directed antimicrobial agents for an average of 6 weeks. All soldiers initially improved, regardless of the specific type of therapy. Patients were followed up to 23 months after completing therapy, and none had recurrent infection with Acinetobacter species. Despite the drug resistance that infecting organisms demonstrated in this series, a regimen of carefully selected extended antimicrobial-drug therapy appears effective for osteomyelitis caused by MDR Acinetobacter soo.
引用
收藏
页码:1218 / 1224
页数:7
相关论文
共 50 条
  • [1] Tetracyclines for multidrug-resistant Acinetobacter baumannii infections
    Falagas, Matthew E.
    Vardakas, Konstantinos Z.
    Kapaskelis, Anastasios
    Triarides, Nikolaos A.
    Roussos, Nikolaos S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (05) : 455 - 460
  • [2] Drug treatment for multidrug-resistant Acinetobacter baumannii infections
    Bassetti, Matteo
    Righi, Elda
    Esposito, Silvano
    Petrosillo, Nicola
    Nicolini, Laura
    FUTURE MICROBIOLOGY, 2008, 3 (06) : 649 - 660
  • [3] Multidrug-resistant Acinetobacter infections:: An emerging challenge to clinicians
    Jain, R
    Danziger, LH
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : 1449 - 1459
  • [4] An Update on the arsenal for multidrug-resistant Acinetobacter infections: Polymyxin antibiotics
    Kassamali, Zahra
    Jain, Rupali
    Danziger, Larry H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 30 : 125 - 132
  • [5] Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
    Bassetti, M.
    Repetto, E.
    Righi, E.
    Boni, S.
    Diverio, M.
    Molinari, M. P.
    Mussap, M.
    Artioli, S.
    Ansaldi, F.
    Durando, P.
    Orengo, G.
    Pallavicini, F. Bobbio
    Viscoli, C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) : 417 - 420
  • [6] Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
    Karageorgopoulos, Drosos E.
    Falagas, Matthew E.
    LANCET INFECTIOUS DISEASES, 2008, 8 (12): : 751 - 762
  • [7] A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections
    Ritchie, David J.
    Garavaglia-Wilson, Alexandria
    CLINICAL INFECTIOUS DISEASES, 2014, 59 : S374 - S380
  • [8] Multidrug-resistant Acinetobacter baumannii
    Krcmery, Vladimir
    Kalavsky, Erich
    EMERGING INFECTIOUS DISEASES, 2007, 13 (06) : 943 - 944
  • [9] Multidrug-resistant Acinetobacter baumannii
    Abbo, A
    Navon-Venezia, S
    Orly, HM
    Krichali, T
    Siegman-Igra, Y
    Carmeli, Y
    EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 22 - 29
  • [10] Multidrug-resistant Acinetobacter infections in US military personnel, 2003 to 2005
    Davis, Kepler A.
    Moran, Kimberly A.
    EMERGING INFECTIONS 7, 2007, 7 : 309 - +